Oxbow Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-181,587
| Closed | -$1.37M | – | 256 |
|
|
2022
Q2 | $1.37M | Buy |
181,587
+7,080
| +4% | +$53.3K | 0.19% | 86 |
|
|
2022
Q1 | $1.64M | Buy |
+174,507
| New | +$1.64M | 0.16% | 87 |
|
|
2017
Q3 | – | Sell |
-6,428
| Closed | -$214K | – | 247 |
|
|
2017
Q2 | $214K | Buy |
+6,428
| New | +$214K | 0.04% | 212 |
|
|
2017
Q1 | – | Sell |
-96,285
| Closed | -$3.49M | – | 274 |
|
|
2016
Q4 | $3.49M | Buy |
+96,285
| New | +$3.49M | 0.44% | 64 |
|
|
2014
Q2 | – | Sell |
-40,695
| Closed | -$2.15M | – | 225 |
|
|
2014
Q1 | $2.15M | Hold |
40,695
| – | – | 0.32% | 77 |
|
|
2013
Q4 | $1.63M | Hold |
40,695
| – | – | 0.23% | 95 |
|
|
2013
Q3 | $1.54M | Buy |
40,695
+2,475
| +6% | +$93.5K | 0.25% | 87 |
|
|
2013
Q2 | $1.5M | Buy |
+38,220
| New | +$1.5M | 0.26% | 76 |
|